AG
ICUI icon

Aperio Group’s ICU Medical ICUI Stock Holding History

Aperio Group’s Portfolio ICUI Stock Details ICUI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$5.97M Buy
27,854
+6,810
+32% +$1.32M 0.02% 750
2020
Q3 		$3.85M Sell
21,044
-1,105
-5% -$208K 0.01% 823
2020
Q2 		$4.08M Sell
22,149
-6,654
-23% -$1.32M 0.02% 797
2020
Q1 		$5.81M Sell
28,803
-2,110
-7% -$406K 0.03% 600
2019
Q4 		$5.79M Buy
30,913
+14,585
+89% +$2.51M 0.02% 686
2019
Q3 		$2.61M Buy
16,328
+7,997
+96% +$1.59M 0.01% 951
2019
Q2 		$2.1M Sell
8,331
-443
-5% -$103K 0.01% 1031
2019
Q1 		$2.1M Buy
8,774
+120
+1% +$28.8K 0.01% 1017
2018
Q4 		$1.99M Sell
8,654
-643
-7% -$159K 0.01% 991
2018
Q3 		$2.63M Buy
9,297
+11
+0.1% +$3.22K 0.01% 912
2018
Q2 		$2.73M Buy
9,286
+587
+7% +$160K 0.01% 874
2018
Q1 		$2.2M Buy
8,699
+597
+7% +$140K 0.01% 955
2017
Q4 		$1.75M Buy
8,102
+326
+4% +$66K 0.01% 1038
2017
Q3 		$1.45M Buy
7,776
+255
+3% +$44.5K 0.01% 1079
2017
Q2 		$1.3M Buy
7,521
+668
+10% +$107K 0.01% 1113
2017
Q1 		$1.05M Buy
6,853
+12
+0.2% +$1.75K 0.01% 1150
2016
Q4 		$1.01M Buy
6,841
+208
+3% +$30.1K 0.01% 1124
2016
Q3 		$838K Buy
6,633
+320
+5% +$38.6K 0.01% 1186
2016
Q2 		$712K Buy
6,313
+79
+1% +$8.2K 0.01% 1226
2016
Q1 		$649K Sell
6,234
-183
-3% -$17.5K 0.01% 1243
2015
Q4 		$724K Buy
6,417
+851
+15% +$94K 0.01% 1150
2015
Q3 		$609K Sell
5,566
-262
-4% -$28K 0.01% 1198
2015
Q2 		$558K Buy
5,828
+905
+18% +$84.6K 0.01% 1260
2015
Q1 		$459K Buy
4,923
+529
+12% +$46.3K 0.01% 1325
2014
Q4 		$360K Buy
4,394
+1,226
+39% +$94K ﹤0.01% 1396
2014
Q3 		$203K Buy
+3,168
New +$194K ﹤0.01% 1596

Other funds holding ICUI

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NC
Nitorum Capital New York $114M AUM 17.21% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Aperio Group's ICUI Position: Q4 2020 in Review

Aperio Group increased its ICU Medical (ICUI) stake by 32% in Q4 2020, buying an estimated $1.32M and bringing the position to 27,854 shares worth $5.97M. The position accounts for 0.02% of the portfolio, ranked #750.

Aperio Group first reported a position in ICUI in Q3 2014 and has held it in 26 quarters since. 284 funds tracked by Wall St. Rank hold ICUI as of Q4 2020.

  • Aperio Group held 27,854 shares of ICU Medical worth $5.97M as of Q4 2020.
  • Aperio Group bought 6,810 ICU Medical shares in Q4 2020, an estimated $1.32M.
  • ICU Medical made up 0.02% of Aperio Group's portfolio in Q4 2020, its #750 holding.
  • Aperio Group first reported a position in ICU Medical in Q3 2014 and has held it in 26 quarters since.
  • 284 funds tracked by Wall St. Rank held ICU Medical as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.